{"id":176,"title":"Is the Benefit of High-Potency Progestins for Endometrial Hyperplasia Specific to Diminished Ovarian Reserve? [Letter]","title_zh":"高效价孕激素治疗子宫内膜增生的获益是否仅见于卵巢储备功能减退患者？（读者来信）","url":"https://pubmed.ncbi.nlm.nih.gov/42979454","doi":"10.2147/dddt.s666106","pmid":"42979454","journal":"Drug Des Devel Ther","kind":"paper","lang":"en","published_at":"2026-10-30T00:00:00+00:00","fetched_at":"2026-11-08T03:43:57+00:00","authors":["Ye T"],"primary_topic":"oocyte","topics":[{"slug":"oocyte","score":3.0,"hits":["ovarian reserve"]},{"slug":"endometrium","score":3.0,"hits":["endometrial"]},{"slug":"repro-endo","score":3.0,"hits":["diminished ovarian reserve"]}],"topic_score":3.0,"preference_score":0.0,"preference_labels":[],"llm_score":46.0,"final_score":46.0,"score_dims":{"novelty":40,"rigor":25,"impact":35,"relevance":72,"translation":35},"recommend_reason":"属学术通信而非原始研究，无摘要与数据，方法学与结论强度有限；仅对关注孕激素治疗子宫内膜增生及DOR人群分层的读者有一定观点参考价值，可略过。","keywords":["高效价孕激素","子宫内膜增生","卵巢储备功能减退","内分泌治疗","读者来信"],"selected":0,"story_id":null,"llm_provider":"deepseek","llm_model":"deepseek-flash","llm_effort":"low","source_key":"pubmed-gametes","source_name":"PubMed · 配子与性腺","source_tier":1,"mention_count":1,"has_interpretation":false,"journal_key":null,"journal_tier":"unknown","journal_if":null,"is_mock":false,"summary_zh":"本文为发表在《Drug Design, Development and Therapy》的读者来信（Letter），作者就既往研究中“高效价孕激素治疗子宫内膜增生”的获益是否特异于卵巢储备功能减退（DOR）人群提出质疑与讨论。信中指出该获益可能并非DOR特有，并对原研究的亚组划分、人群选择与结论外推提出商榷。由于平台未提供摘要与正文，具体论据、引用数据与作者结论无法核实，本条仅可视为对该议题的学术观点交流，不含原始数据或系统分析。","summary":"","interpretation_basis":null,"fulltext_status":null,"interpretation":null,"fulltext":{"available":false,"status":null,"reason":"尚未抓取全文（未入选、分数未达阈值，或还没跑 fulltext 步骤）","pmcid":null,"license":null,"chars":0,"source":null,"fetched_at":null}}